These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19625522)

  • 41. Blocking GSK3β-mediated dynamin1 phosphorylation enhances BDNF-dependent TrkB endocytosis and the protective effects of BDNF in neuronal and mouse models of Alzheimer's disease.
    Liu XH; Geng Z; Yan J; Li T; Chen Q; Zhang QY; Chen ZY
    Neurobiol Dis; 2015 Feb; 74():377-91. PubMed ID: 25484286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quetiapine modulates conditioned anxiety and alternation behavior in Alzheimer's transgenic mice.
    Tempier A; He J; Zhu S; Zhang R; Kong L; Tan Q; Luo H; Kong J; Li XM
    Curr Alzheimer Res; 2013 Feb; 10(2):199-206. PubMed ID: 22950914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lactobacillus-derived extracellular vesicles counteract Aβ42-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve Aβ pathology in Tg-APP/PS1 mice.
    Kwon H; Lee EH; Park SY; Park JY; Hong JH; Kim EK; Shin TS; Kim YK; Han PL
    Exp Mol Med; 2023 Sep; 55(9):2067-2082. PubMed ID: 37704750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic Effects of Transplantation of As-MiR-937-Expressing Mesenchymal Stem Cells in Murine Model of Alzheimer's Disease.
    Liu Z; Wang C; Wang X; Xu S
    Cell Physiol Biochem; 2015; 37(1):321-30. PubMed ID: 26316079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Expressions of synaptophysin and BDNF/Trk-B in cerebellum of APPswe/PS1dE9 transgenic mice].
    Dong XF; Wang T; Li T; Jiao JJ; Qu XS; Qi JS; Yang W
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):488-492. PubMed ID: 29931895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osthole Upregulates BDNF to Enhance Adult Hippocampal Neurogenesis in APP/PS1 Transgenic Mice.
    Liu H; Xue X; Shi H; Qi L; Gong D
    Biol Pharm Bull; 2015; 38(10):1439-49. PubMed ID: 26424009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Naert G; Rivest S
    J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.
    Rosa E; Mahendram S; Ke YD; Ittner LM; Ginsberg SD; Fahnestock M
    Neurobiol Aging; 2016 Dec; 48():135-142. PubMed ID: 27676333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-206 decreases brain-derived neurotrophic factor levels in a transgenic mouse model of Alzheimer's disease.
    Tian N; Cao Z; Zhang Y
    Neurosci Bull; 2014 Apr; 30(2):191-7. PubMed ID: 24604632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice.
    Biscaro B; Lindvall O; Hock C; Ekdahl CT; Nitsch RM
    J Neurosci; 2009 Nov; 29(45):14108-19. PubMed ID: 19906959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease.
    Wang D; Di X; Fu L; Li Y; Han X; Wu H; Cai L; Meng X; Jiang C; Kong W; Su W
    Neuroreport; 2016 Oct; 27(15):1114-9. PubMed ID: 27541273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.
    Yang DS; Stavrides P; Mohan PS; Kaushik S; Kumar A; Ohno M; Schmidt SD; Wesson D; Bandyopadhyay U; Jiang Y; Pawlik M; Peterhoff CM; Yang AJ; Wilson DA; St George-Hyslop P; Westaway D; Mathews PM; Levy E; Cuervo AM; Nixon RA
    Brain; 2011 Jan; 134(Pt 1):258-77. PubMed ID: 21186265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
    Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
    Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer's disease.
    Adlard PA; Perreau VM; Pop V; Cotman CW
    J Neurosci; 2005 Apr; 25(17):4217-21. PubMed ID: 15858047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
    Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
    Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smilagenin induces expression and epigenetic remodeling of BDNF in alzheimer's disease.
    Yang S; Fan L; Zhang R; Song C; Shi J; Wang J; Zhang P; Wang H; Zhang Y
    Phytomedicine; 2023 Sep; 118():154956. PubMed ID: 37499345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.